MedTrace Logo

Inflammation in Peritoneal Dialysis Patients: Effect of Obesity

NCT01691196 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-10-29

No results posted yet for this study

Summary

Our study addresses the following research question: What is the role of obesity in modulating inflammation and innate immune function, as well as the overall responsiveness of innate immune cells (such as macrophages, neutrophils, and other peripheral leukocytes) in patients undergoing peritoneal dialysis?

The investigators hypothesize that obesity will lead to increased inflammation in patients undergoing peritoneal dialysis.

Conditions

  • End-Stage Renal Disease
  • Renal Disease, End-Stage
  • Renal Failure, End-Stage
  • Obesity

Sponsors & Collaborators

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Jerrold S Levine, MD · UIC

  • Natalia Litbarg, MD · UIC

  • Giamila Fantuzzi, PhD · UIC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01691196 on ClinicalTrials.gov